Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-010314
Filing Date
2021-02-01
Accepted
2021-02-01 17:19:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm213941-1_s3.htm S-3 289783
2 EXHIBIT 5.1 tm213941d2_ex5-1.htm EX-5.1 32626
3 EXHIBIT 23.1 tm213941d2_ex23-1.htm EX-23.1 2364
4 GRAPHIC lg_annovis-4c.jpg GRAPHIC 28989
5 GRAPHIC tm213941d2_ex5-1img001.jpg GRAPHIC 2500
6 GRAPHIC tm213941d2_ex5-1img002.jpg GRAPHIC 1746
  Complete submission text file 0001104659-21-010314.txt   372057
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252625 | Film No.: 21577832
SIC: 2834 Pharmaceutical Preparations